These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11325634)

  • 1. Ribozyme gene therapy: applications for molecular medicine.
    Lewin AS; Hauswirth WW
    Trends Mol Med; 2001 May; 7(5):221-8. PubMed ID: 11325634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribozymes in the age of molecular therapeutics.
    Bagheri S; Kashani-Sabet M
    Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of ribozymes.
    Kijima H; Ishida H; Ohkawa T; Kashani-Sabet M; Scanlon KJ
    Pharmacol Ther; 1995; 68(2):247-67. PubMed ID: 8719970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of group I intron-based trans-splicing ribozymes.
    Lee CH; Han SR; Lee SW
    Wiley Interdiscip Rev RNA; 2018 May; 9(3):e1466. PubMed ID: 29383855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozymes: a modern tool in medicine.
    Khan AU; Lal SK
    J Biomed Sci; 2003; 10(5):457-67. PubMed ID: 12928586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozymes in gene therapy of HIV-1.
    Macpherson JL; Ely JA; Sun LQ; Symonds GP
    Front Biosci; 1999 Jun; 4():D497-505. PubMed ID: 10352136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic hammerhead ribozymes as therapeutic tools to control disease genes.
    Citti L; Rainaldi G
    Curr Gene Ther; 2005 Feb; 5(1):11-24. PubMed ID: 15638708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairpin ribozyme gene therapy for AIDS.
    Duarte EA; Leavitt MC; Yamada O; Yu M
    Methods Mol Biol; 1997; 74():459-68. PubMed ID: 9204461
    [No Abstract]   [Full Text] [Related]  

  • 10. Ribozyme and peptide-nucleic acid-based gene therapy.
    Phylactou LA
    Adv Drug Deliv Rev; 2000 Nov; 44(2-3):97-108. PubMed ID: 11072108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribozyme gene therapy for autosomal dominant retinal disease.
    Hauswirth WW; LaVail MM; Flannery JG; Lewin AS
    Clin Chem Lab Med; 2000 Feb; 38(2):147-53. PubMed ID: 10834402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and characterizing hammerhead ribozymes for use in AAV vector-mediated retinal gene therapies.
    Fritz JJ; White DA; Lewin AS; Hauswirth WW
    Methods Enzymol; 2002; 346():358-77. PubMed ID: 11883079
    [No Abstract]   [Full Text] [Related]  

  • 13. Engineered ribozymes as molecular tools for site-specific alteration of RNA sequence.
    Müller S
    Chembiochem; 2003 Oct; 4(10):991-7. PubMed ID: 14523916
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic applications of catalytic antisense RNAs (ribozymes).
    Rossi JJ
    Ciba Found Symp; 1997; 209():195-204; discussion 204-6. PubMed ID: 9383577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes.
    Byun J; Lan N; Long M; Sullenger BA
    RNA; 2003 Oct; 9(10):1254-63. PubMed ID: 13130139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the substrate specificity of a group I intron ribozyme.
    Zarrinkar PP; Sullenger BA
    Biochemistry; 1999 Mar; 38(11):3426-32. PubMed ID: 10079089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.
    Shin KS; Sullenger BA; Lee SW
    Mol Ther; 2004 Aug; 10(2):365-72. PubMed ID: 15294183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and Ribozymes.
    Scarborough RJ; Gatignol A
    Adv Exp Med Biol; 2015; 848():97-116. PubMed ID: 25757617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of ribozymes for gene therapy.
    Sullivan SM
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):85S-89S. PubMed ID: 7963690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.